Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 11 of about 10 companies and 1 funds for Christopher L. White
Company Exchange Symbol Last price Quote change Market cap
Align Technology, Inc. NASDAQ ALGN 53.10 -0.02 (-0.04%) 4.33B
Align Technology, Inc (Align), designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and ...
Executive:
Christopher C. Puco
Hillshire Brands Co NYSE HSH 62.81 +0.01 (0.02%) 7.75B
The Hillshire Brands Company is a manufacturer and marketer of food products. The Company's portfolio includes brands, such as Jimmy Dean, Ball Park, ...
Executive:
Christopher B. Begley
Rent-A-Center Inc NASDAQ RCII 25.01 -0.12 (-0.48%) 1.32B
Rent-A-Center, Inc. is a rent-to-own operator in North America. It provides the customers the ownership of durable products, such as consumer electronics, ...
Executive:
Christopher A. Korst
Era Group Inc NYSE ERA 28.46 +0.10 (0.35%) 579.01M
Era Group Inc. is engaged in helicopter operations worldwide. The Company's helicopters are primarily used to transport personnel to, from and between ...
Executive:
Christopher Pashalis Papouras
Parks! America, Inc. OTCMKTS PRKA 0.0520 0.0000 (0.00%) 3.86M
Parks! America, Inc. (Parks! America), through its wholly owned subsidiaries, owns and operates two regional theme parks and is in the business of acquiring ...
Executive:
Christopher L. Eastland
UNITE Group plc LON UTG 407.00 -2.20 (-0.54%) 818.72M
The UNITE Group plc is engaged in the development and management of student residential accommodation in the United Kingdom.
Executive:
Christopher Szpojnarowicz
Chinook Energy Inc. TSE CKE 2.11 -0.10 (-4.52%) 451.94M
Chinook Energy Inc. (Chinook) is a Calgary-based public oil and natural gas exploration and development company with predominately natural gas and liquids ...
Executive:
Christopher B. Laing
Oxford Pharmascience Group Plc LON OXP 4.56 +0.03 (0.77%) 45.86M
Oxford Pharmascience Group plc is a specialist pharmaceutical technology company . The Company is engaged in developing and licensing solutions to add value ...
Executive:
Christopher Hill
Covidien plc NYSE COV 89.10 -0.19 (-0.21%) 40.17B
Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
Executive:
Christopher J. Coughlin
Covidien plc FRA 6COP 65.57 -0.43 (-0.66%)
Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
Executive:
Christopher J. Coughlin
Mutual Fund Symbol Nav Nav change
Cornerstone Advisors Global Public Equity Fund Institutional Shares CAGLX 13.43 +0.01 (0.07%)
The investment seeks capital appreciation. The fund allocates its assets among one or more investment strategies directly through the use of one or more ...
Executive:
Christopher K. McHugh